Wednesday, 20 July 2016
Fish Oil Market Growth Undeterred by Amphibious Beliefs
The wondrous expansion of world fish oil market in recent past, leaves the stakeholders asking for more research and development to validate its benefits.
Fish oil supplement is the third most widely used supplement type in the United States. A general survey estimates that around 10% of total American population claims its regular intake. The companies operating in this segment harp on the acclaimed cardiovascular health benefits of fish oil. Added to that, the protective resolvin molecules present in omega-3 fatty acids, are credited to correct blood sugar levels, improve drug metabolism, and deal with organ inflammation. A diverse set of fish oil uses are cited among population all over the world. Scarcely accurate data derived from hither and tither sources, are available backed by circumstantial research evidence. Even if there were types of fish oil that could lower the risk of cardiac arrests or strokes, the supplement available on consumer platforms are no match for them. However, there is no total denial for the benefits of fish oil supplements and the market is bound to rise with leaps and bounds curing the current decade. Analytical experts from Allied Market Research reiterate the commendable market size and growth of fish oil.
In a certain article published in the Journal of Neurophysiology, a group of researchers have concluded on the benefits of fish oil for treating diabetic neuropathy efficaciously. During initial trials, a batch of mice was inflicted with Type II diabetic symptoms through high-glucose diet. After eight weeks of confirmed hyperglycemia, half of the batch was fed with menhaden oil. While this batch exhibited better sensory conduction, the other one was detected to be thermally hypoalgesic, and sensed poorly. Exogenous feeding of resolvin D1, stimulated nerve projections and its growth.
Conclusive notes, remarked that n-3 polyunsaturated fatty acids extracted from fish oil could effectively treat diabetic neuropathy. The findings of this study is crucial with respect to the fact that almost five out of every 10 diabetic patients suffer from peripheral nerve dysfunction. Such throughputs, fuel hope for finding therapeutic applications of fish oil pills, in commercial market.
Referring to the earlier mention of improvement in liver function, mainly drug metabolism, there has been evidentiary progress. In another independent research studies, fish oil vitamin supplements have been found to enhance the performance of anti-depressant drugs. Statistics from over 40 clinical reviews were used as evidence to prove the fact. The conducting group comprised students from Melbourne University and Harvard School of Medical Science.
"This is an exciting finding because here we have a safe, evidence-based approach that could be considered a mainstream treatment," approved the research leader, Dr. Jerome Sarris.
However, the group has not yet established exact interaction between Omega-3 and the anti-depressants. This leaves scope for further research in the fish oil segment, which of course, the industry looks forward to. Concentrated investments for research and development activities will be a shot in the arm for the fish oil industry.
Experts explain that, it is the oxidation of fish oil that poses the main issue here. The process can turn the cards against speculated benefits of the same. Ones that can be confidently prescribed to patients, needs to gain appropriate approvals from U.S. Food and Drug Administration (FDA) before they are commercially circulated. The regulatory mandates would ensure that correct handling of fish oil is maintained during production, packaging, and distribution. This implies, the manufacturers and vendors follow strict procedures that refrain any feasible contact between fish oil and oxygen throughout their lifecycle outside a patient’s body. Lack of appropriate interference from the FDA explains why corporate giants are hesitant to expand in this segment. Despite these limitations, the market continues to grow into a multimillion affair taking advantage of the regulatory gaps.
Fish Information and Services (FIS) recently released the remarkable figures supporting the exemplary growth of the fish oil market. The news of industry gaining strength came from Angola. A 272.2% increase in production volume for fish oil was registered in the area between 2014 to 2015. This significant rise of market has been attributed to the management dealings introduced by the Presidential Decree 11/16. The decree mandates limited regional participation, but with a sustainable approach. Improved government provisions, in terms of equipment and subsidies, also motivate more streamlined tactics in export, and/or import activities. This stands as an example of how regional players can be enforced to combine their efforts in order to maximize outputs, without degrading available local resources.